Clinical Roundup Keytruda improves OS for high-risk early-stage TNBC in phase III trial May 31, 2024Vol.50 No.22
Clinical Roundup Scemblix improves MMR rates for Ph+ CML-CP in phase III trial May 31, 2024Vol.50 No.22
Clinical Roundup Kisqali reduces risk of cancer recurrence for HR+/HER2- early breast cancer in phase III trial May 31, 2024Vol.50 No.22
Clinical Roundup REGN7075 + Libtayo leads to anti-tumor responses in MSS colorectal cancer in dose-escalation portion of phase I/II study May 31, 2024Vol.50 No.22
Clinical Roundup Lifileucel + pembrolizumab show promise for advanced melanoma in data from phase II study May 31, 2024Vol.50 No.22
Clinical Roundup Combination therapy improves PFS, OS for metastatic colorectal cancer in phase Ib/II study May 31, 2024Vol.50 No.22
Clinical Roundup Datopotamab deruxtecan did not reach statistical significance for OS in metastatic or advanced nonsquamous NSCLC in phase III trial May 31, 2024Vol.50 No.22
Clinical Roundup ACCC and LUNGevity launch virtual roadmap to support EHR integration for biomarker testing May 31, 2024Vol.50 No.22
